Molly Li
MBBS, FHKAM
Assistant Professor, Department of Clinical Oncology
The Chinese University of Hong Kong
Aug 15, 2025
Episode
307
Soundcloud
Share
As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Molly Li moderates a discussion in Cantonese with Dr. Rina Hui and Dr. Zhang Li. This episode is part of our Virtual Tumor Board series and will focus on managing EGFR-mutant NSCLC.
Guest
Rina Hui
MBBS, PhD, FRACP
Director, Centre of Cancer Medicine
HKU Med
Clinical Professor, University of Hong Kong
Adjunct Professor, University of Sydney
Zhang Li
MD
Professor, Medical Oncology Department Deputy Director
Lung Cancer Research Center Sun Yat-Sen University
